In addition, to promote tumorigenesis, METTL3 promotes chemotherapy and radiation tolerance, which has been identified as associated with mitogen-activated protein kinase (MAPK) cascades, a ubiquitin-dependent modification in pancreatic cancer (48). This evidence concerns the gene METTL3 and familial pancreatic carcinoma.